R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma

Bibliographic Details
Main Authors:	Diana Al-Sarayfi, Frederik O. Meeuwes, Müjde Durmaz, Djamila E. Issa, Rolf E. Brouwer, Aart Beeker, Anna van Rhenen, Pim G. N. J. Mutsaers, Lara H. Böhmer, Marjolein W. M. van der Poel, Liane te Boome, Tom van Meerten, Martine E. D. Chamuleau, Josée M. Zijlstra, Mirian Brink, Marcel Nijland
Format:	Article
Language:	English
Published:	Nature Publishing Group 2022-09-01
Series:	Blood Cancer Journal
Online Access:	https://doi.org/10.1038/s41408-022-00723-4

Internet